Uniqure NV Schedule 13G passive stakes

RTW Investments, LP and Roderick Wong, M.D. have filed a Schedule 13G, disclosing beneficial ownership of 5.7% of uniQure N.V.'s ordinary shares as of June 30, 2026.

Aberdeen Group plc and abrdn Inc. have reported a combined beneficial ownership of 4.52% in uniQure N.V. ordinary shares as of June 30, 2026.

JPMorgan Chase & Co. has reported beneficial ownership of 7.0% of uniQure N.V.'s ordinary shares as of June 30, 2026.

RTW Investments, LP and Roderick Wong have reported beneficial ownership of 4.1% of uniQure N.V.'s ordinary shares as of March 31, 2026.

State Street Corporation has reported beneficial ownership of 3.6% of Uniqure NV's common stock as of March 31, 2026.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 2.8% of Uniqure N.V.'s common stock as of March 31, 2026.

Avoro Capital Advisors and Behzad Aghazadeh have reported a 9.87% beneficial ownership stake in uniQure N.V., holding 6,150,000 ordinary shares.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 6.0% beneficial ownership stake in uniQure N.V. as of December 31, 2025.

A group of affiliated entities, including Susquehanna Securities, LLC, has disclosed a 5.7% beneficial ownership stake in uniQure N.V. as of December 31, 2025.

State Street Corporation has reported a 5.2% beneficial ownership stake in UNIQURE NV, holding over 3.2 million common shares.

Aberdeen Group plc and abrdn Inc. have disclosed a 5.91% beneficial ownership stake in uniQure N.V. as of December 31, 2025.

Vestal Point Capital, LP and Ryan Wilder have filed an Amendment No. 5 to Schedule 13G, disclosing a beneficial ownership of 0.4% of uniQure N.V.'s Ordinary Shares.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 7.2% beneficial ownership stake in uniQure N.V. ordinary shares.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 9.8% of UNIQURE N.V.'s common stock as of September 30, 2025.

Aberdeen Group plc and abrdn Inc. have disclosed a shared beneficial ownership of 4.77% in uniQure N.V., totaling 2,939,743 ordinary shares.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, filed an amendment to their Schedule 13G, disclosing a 3.75% beneficial ownership in uniQure N.V. as of June 30, 2025.

Vestal Point Capital and Ryan Wilder have disclosed a 6.8% beneficial ownership stake in uniQure N.V., holding 3.7 million ordinary shares.

RTW Investments, LP and Roderick Wong, M.D. have disclosed a 9.4% beneficial ownership stake in uniQure N.V.'s Ordinary Shares.

Avoro Capital Advisors and Behzad Aghazadeh have disclosed a 6.6% beneficial ownership stake in uniQure N.V., acquired for investment purposes.

Aberdeen Group plc and its subsidiary abrdn Inc. have reported a beneficial ownership of 5.02% in uniQure N.V.'s Ordinary Shares.

Vestal Point Capital, LP and Ryan Wilder have filed an amendment to their Schedule 13G, confirming their beneficial ownership of 8.9% of uniQure N.V.'s ordinary shares as of March 31, 2025.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a 7.9% beneficial ownership stake in uniQure N.V. as of March 31, 2025, through a Schedule 13G filing.

Vestal Point Capital, LP and Ryan Wilder have disclosed a passive beneficial ownership of 6.2% of uniQure N.V.'s Ordinary Shares, totaling 3,025,000 shares, as of December 31, 2024.